lexibulin (CYT997) / Gilead  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
lexibulin (CYT997) / Gilead
ACTRN12606000520538: Phase I accelerated dose-escalation study of CYT997 given as an oral capsule every two weeks in patients with advanced solid tumours

Completed
1
15
 
Cytopia Research Pty Ltd, Cytopia Research Pty Ltd
Cancer - solid malignancies that are metastatic or unresectable
 
 
ACTRN12605000793617: Phase I dose-escalation study for CYT997

Completed
1
24
 
Cytopia Research Pty Ltd, Cytopia Research Pty Ltd
Cancer - solid malignancies that are metastatic or unresectable
 
 

Download Options